Genprex racks up $10 mln
Austin, Texas-based Genprex Inc, a developer of immunogene therapy for non-small cell lung cancer, has raised $10 million in a private placement. The investors were not identified. Maxim Group LLC was the placement agent.
8 May 2018•3 mins read
